Aviva
ACAD icon

Aviva’s Acadia Pharmaceuticals ACAD Stock Holding History

Aviva’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$452K Buy
20,302
+991
+5% +$23.7K ﹤0.01% 729
2025
Q4 		$516K Sell
19,311
-942
-5% -$22.5K ﹤0.01% 730
2025
Q3 		$432K Sell
20,253
-877
-4% -$20.7K ﹤0.01% 840
2025
Q2 		$456K Sell
21,130
-13,117
-38% -$244K ﹤0.01% 812
2025
Q1 		$569K Sell
34,247
-1,636
-5% -$29.7K ﹤0.01% 762
2024
Q4 		$658K Buy
+35,883
New +$579K ﹤0.01% 657
2021
Q1 		– Sell
-30,740
Closed -$1.64M – 939
2020
Q4 		$1.64M Sell
30,740
-24,922
-45% -$1.24M 0.01% 733
2020
Q3 		$2.3M Buy
55,662
+8,240
+17% +$356K 0.01% 693
2020
Q2 		$2.3M Buy
+47,422
New +$2.28M 0.01% 690

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return